Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-07 12:54 pm Sale | 2022-12-31 | 13G | Exagen Inc. XGN | TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,857,949 11.380% | -10,190 (-0.55%) | Filing History |
| 2023-02-06 12:23 pm Sale | 2022-12-31 | 13G | Exagen Inc. XGN | BANK OF MONTREAL BMO | 0 0.000% | -1,015,612 (Position Closed) | Filing History |
| 2023-02-02 4:16 pm Unchanged | 2022-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,308,958 14.150% | 0 (Unchanged) | Filing History |
| 2023-01-23 5:13 pm Sale | 2022-12-30 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 966,022 5.920% | -418,609 (-30.23%) | Filing History |
| 2022-11-23 2:40 pm Purchase | 2022-11-14 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 833,305 5.100% | 833,305 (New Position) | Filing History |
| 2022-02-15 09:48 am Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | BANK OF MONTREAL BMO | 1,015,612 6.300% | 1,015,612 (New Position) | Filing History |
| 2022-02-14 1:10 pm Sale | 2021-12-31 | 13G | Exagen Inc. XGN | TULLIS DICKERSON CAPITAL FOCUS III L.P. | 1,868,139 11.560% | -22,383 (-1.18%) | Filing History |
| 2022-02-14 08:56 am Sale | 2021-12-31 | 13G | Exagen Inc. XGN | RTW Investments, LP | 821,414 5.100% | -428,717 (-34.29%) | Filing History |
| 2022-02-11 7:26 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management, LLC | 858,567 5.300% | 25,030 (+3.00%) | Filing History |
| 2022-02-11 2:09 pm Sale | 2022-02-11 | 13G | Exagen Inc. XGN | Wasatch Advisors LP | 1,105,760 6.800% | -585,747 (-34.63%) | Filing History |
| 2022-02-10 4:15 pm Unchanged | 2021-12-31 | 13G | Exagen Inc. XGN | NMSIC Co-Investment Fund, L.P. | 2,308,958 14.280% | 0 (Unchanged) | Filing History |
| 2022-02-08 4:10 pm Sale | 2021-12-31 | 13G | Exagen Inc. XGN | Hunt Holdings Limited Partnership | 1,011,324 6.260% | -248,350 (-19.72%) | Filing History |
| 2022-01-20 10:46 am Unchanged | 2021-12-31 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 1,384,631 8.570% | 0 (Unchanged) | Filing History |
| 2022-01-19 4:21 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 1,384,631 8.570% | 511,000 (+58.49%) | Filing History |
| 2021-12-23 5:33 pm Purchase | 2021-12-20 | 13G | Exagen Inc. XGN | Stonepine Capital Management, LLC | 833,537 5.200% | 833,537 (New Position) | Filing History |
| 2021-12-17 3:57 pm Purchase | 2021-09-10 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 873,631 5.410% | 873,631 (New Position) | Filing History |
| 2021-04-09 2:00 pm Purchase | 2021-04-09 | 13G | Exagen Inc. XGN | Wasatch Advisors LP | 1,691,507 10.000% | 647,104 (+61.96%) | Filing History |